A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

被引:119
作者
Green, AR
O'Shea, E
Colado, MI
机构
[1] AstraZeneca R&D Charnwood, Loughborough LE11 5RH, Leics, England
[2] De Montfort Univ, Sch Pharm, Neuropharmacol Res Grp, Leicester LE1 9BH, Leics, England
[3] Univ Complutense Madrid, Fac Med, Dept Farmacol, E-28040 Madrid, Spain
关键词
3,4-methylenedioxymethamphetamine; ecstasy; hyperthermia; neurotoxicity; serotonin; body temperature;
D O I
10.1016/j.ejphar.2004.07.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The predominant severe acute adverse effect following ingestion of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) by recreational users is hyperthermia which can induce other associated clinical problems and occasionally death. There is no pharmacologically specific treatment. MDMA also induces dose-dependent hyperthermia in experimental animals. This review examines the consequences of MDMA administration on body temperature in humans and rodents. In rats hyperthermia results primarily from dopamine release and is influenced by dose, ambient temperature and other housing conditions. The response is increased in rats with a prior MDMA-induced neurotoxic lesion of 5-hydroxytryptamine (5-HT) nerve endings. Increased MDMA-induced locomotor activity appears to play no role in the hyperthermic response. However, the size of the acute hyperthermic response plays a major role in determining the severity of the subsequent neurotoxicity. These results suggest that any MDMA-induced hyperthermic response will be enhanced in hot, crowded dance club conditions and that ingesting the drug in such conditions increases the possibility of subsequent cerebral neurotoxic effect. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 78 条
[61]  
Nguyen KT, 1998, J NEUROSCI, V18, P2239
[62]   Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain [J].
O'Shea, E ;
Esteban, B ;
Camarero, J ;
Green, AR ;
Colado, MI .
NEUROPHARMACOLOGY, 2001, 40 (01) :65-74
[63]   The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy') [J].
O'Shea, E ;
Granados, R ;
Esteban, B ;
Colado, MI ;
Green, AR .
NEUROPHARMACOLOGY, 1998, 37 (07) :919-926
[64]   3,4-Methylenedioxymethamphetamine increases interleukin-1β levels and activates microglia in rat brain:: studies on the relationship with acute hyperthermia and 5-HT depletion [J].
Orio, L ;
O'Shea, E ;
Sanchez, V ;
Pradillo, JM ;
Escobedo, I ;
Camarero, J ;
Moro, MA ;
Green, AR ;
Colado, MI .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (06) :1445-1453
[65]   Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity [J].
Parrott, AC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) :837-844
[66]   INDUCTION OF INTERLEUKIN-1 IN VARIOUS BRAIN-REGIONS AFTER PERIPHERAL AND CENTRAL INJECTIONS OF LIPOPOLYSACCHARIDE [J].
QUAN, N ;
SUNDAR, SK ;
WEISS, JM .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 49 (1-2) :125-134
[67]   Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats [J].
Sanchez, V ;
Camarero, J ;
O'Shea, E ;
Green, AR ;
Colado, MI .
NEUROPHARMACOLOGY, 2003, 44 (04) :449-461
[68]   The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain [J].
Sanchez, V ;
Camarero, J ;
Esteban, B ;
Peter, MJ ;
Green, AR ;
Colado, MI .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (01) :46-57
[69]  
SANCHEZ V, 2004, J PSYCHOPHARMACOL, V18, P375
[70]   A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities [J].
Schifano, F .
PSYCHOPHARMACOLOGY, 2004, 173 (3-4) :242-248